autoparts

Просмотров: 0
2 обсуждают
000000000x
·
--
Статья
HL Mando's Profit Halved — But Goldman Keeps Its Buy on the Humanoid-Robot BetHL Mando's Profit Halved — But Goldman Keeps Its Buy on the Humanoid-Robot Bet $204320.KS GOLDMAN SACHS GLOBAL INVESTMENT RESEARCH | DO HYOUNG KIM, JOSHUA KIM • 30 October 2026 1. What happened in 3Q26 — and why did profit miss so badly? • Revenue was KRW2,321bn — flat year on year and down 7.0% quarter on quarter, broadly in line with consensus. • Operating profit was just KRW52bn, down 45.3% year on year, with the margin at 2.2% — 37.8% below Goldman's estimate and 44.2% below Bloomberg consensus. • Three drivers: KRW26bn of raw-material inflation from Middle East tensions, KRW16bn of higher system-chip prices, and R&D up KRW23.5bn year on year on humanoid actuators, EMB and HL Klemove's HPC project. • Strip those out and normalised operating profit is about KRW95bn at a 4.1% margin — broadly in line with estimates. The miss is about costs and investment, not demand. 2. What did Goldman Sachs change — and what did it leave alone? • Target price cut to KRW94,000 from KRW109,000, while the Buy rating is maintained. • EPS forecasts cut 18% for 2026, 19% for 2027 and 17% for 2028; revenue forecasts are unchanged (2026E KRW9,638bn; 2027E KRW10,146bn; 2028E KRW10,940bn). • Full-year 2026 operating margin is now seen at 3.7%, below management's 4.0% guidance, which Goldman Sachs calls difficult to meet; the low-single-digit revenue growth guidance is on track. • At the report's KRW37,050 price (30 October close), the new target still implies 153.7% upside. 3. Why stay Buy after a miss — what's the humanoid-robot actuator story? • The roadmap is on track: master actuator products finalised by end-2026, customer bidding with global Tier-1 and Tier-2 robotics makers in early 2027, and meaningful revenue targeted from 2028. • In Alabama, dedicated lines are being built for 2027 mass production of quasi-direct-drive (QDD) actuators, targeting a 15–20% wallet share with key humanoid clients — a target, not secured orders. • Order momentum supports the story: KRW7.6tn of new orders in 9M26, with KRW5.4tn more needed in 4Q to reach the KRW13tn full-year target; management is confident. • Goldman Sachs is explicit: a re-rating hinges on visible robotics orders — the actuator business, not the auto-parts cycle, is the thesis. 4. What could go wrong — and what should investors watch? • If no substantial actuator order lands by end-2027, the key catalyst is absent, in Goldman's view. • Watch next: 4Q order intake (KRW5.4tn needed), the early-2027 bidding rounds, and the Alabama ramp. • Other risks Goldman Sachs cites: higher North America capex, end-market demand pressure on margins, a stagnant ADAS business and persistent cost inflation. #HumanoidRobots #Robotics #AI #AutoParts #Korea Source: Goldman Sachs Global Investment Research, 30 October 2026. Based solely on the report provided; forecasts are not guaranteed. For reference only; not investment advice. Read the full breakdown on Unhidea: https://unhidea.com/en/articles/research-c3a686906990453489fcfb879a5a76fc-en Visit unhidea.com for more of the latest sell-side research interpretations.

HL Mando's Profit Halved — But Goldman Keeps Its Buy on the Humanoid-Robot Bet

HL Mando's Profit Halved — But Goldman Keeps Its Buy on the Humanoid-Robot Bet
$204320.KS
GOLDMAN SACHS GLOBAL INVESTMENT RESEARCH | DO HYOUNG KIM, JOSHUA KIM • 30 October 2026
1. What happened in 3Q26 — and why did profit miss so badly?
• Revenue was KRW2,321bn — flat year on year and down 7.0% quarter on quarter, broadly in line with consensus.
• Operating profit was just KRW52bn, down 45.3% year on year, with the margin at 2.2% — 37.8% below Goldman's estimate and 44.2% below Bloomberg consensus.
• Three drivers: KRW26bn of raw-material inflation from Middle East tensions, KRW16bn of higher system-chip prices, and R&D up KRW23.5bn year on year on humanoid actuators, EMB and HL Klemove's HPC project.
• Strip those out and normalised operating profit is about KRW95bn at a 4.1% margin — broadly in line with estimates. The miss is about costs and investment, not demand.
2. What did Goldman Sachs change — and what did it leave alone?
• Target price cut to KRW94,000 from KRW109,000, while the Buy rating is maintained.
• EPS forecasts cut 18% for 2026, 19% for 2027 and 17% for 2028; revenue forecasts are unchanged (2026E KRW9,638bn; 2027E KRW10,146bn; 2028E KRW10,940bn).
• Full-year 2026 operating margin is now seen at 3.7%, below management's 4.0% guidance, which Goldman Sachs calls difficult to meet; the low-single-digit revenue growth guidance is on track.
• At the report's KRW37,050 price (30 October close), the new target still implies 153.7% upside.
3. Why stay Buy after a miss — what's the humanoid-robot actuator story?
• The roadmap is on track: master actuator products finalised by end-2026, customer bidding with global Tier-1 and Tier-2 robotics makers in early 2027, and meaningful revenue targeted from 2028.
• In Alabama, dedicated lines are being built for 2027 mass production of quasi-direct-drive (QDD) actuators, targeting a 15–20% wallet share with key humanoid clients — a target, not secured orders.
• Order momentum supports the story: KRW7.6tn of new orders in 9M26, with KRW5.4tn more needed in 4Q to reach the KRW13tn full-year target; management is confident.
• Goldman Sachs is explicit: a re-rating hinges on visible robotics orders — the actuator business, not the auto-parts cycle, is the thesis.
4. What could go wrong — and what should investors watch?
• If no substantial actuator order lands by end-2027, the key catalyst is absent, in Goldman's view.
• Watch next: 4Q order intake (KRW5.4tn needed), the early-2027 bidding rounds, and the Alabama ramp.
• Other risks Goldman Sachs cites: higher North America capex, end-market demand pressure on margins, a stagnant ADAS business and persistent cost inflation.
#HumanoidRobots #Robotics #AI #AutoParts #Korea
Source: Goldman Sachs Global Investment Research, 30 October 2026. Based solely on the report provided; forecasts are not guaranteed. For reference only; not investment advice.
Read the full breakdown on Unhidea: https://unhidea.com/en/articles/research-c3a686906990453489fcfb879a5a76fc-en
Visit unhidea.com for more of the latest sell-side research interpretations.
Войдите, чтобы посмотреть больше материала
Присоединяйтесь к пользователям криптовалют по всему миру на Binance Square
⚡️ Получайте новейшую и полезную информацию о криптоактивах.
💬 Нам доверяет крупнейшая в мире криптобиржа.
👍 Получите достоверные аналитические данные от верифицированных создателей контента.
Эл. почта/номер телефона